IL95393A0 - Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing - Google Patents

Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing

Info

Publication number
IL95393A0
IL95393A0 IL95393A IL9539390A IL95393A0 IL 95393 A0 IL95393 A0 IL 95393A0 IL 95393 A IL95393 A IL 95393A IL 9539390 A IL9539390 A IL 9539390A IL 95393 A0 IL95393 A0 IL 95393A0
Authority
IL
Israel
Prior art keywords
masked
odor
wound healing
skin conditions
promoting wound
Prior art date
Application number
IL95393A
Original Assignee
John Morris Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Morris Co filed Critical John Morris Co
Publication of IL95393A0 publication Critical patent/IL95393A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645Proteins of vegetable origin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00Manicure or pedicure preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54Polymers characterized by specific structures/properties
    • A61K2800/542Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5426Polymers characterized by specific structures/properties characterized by the charge cationic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL95393A 1989-08-18 1990-08-16 Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing IL95393A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39647489A 1989-08-18 1989-08-18

Publications (1)

Publication Number Publication Date
IL95393A0 true IL95393A0 (en) 1991-06-30

Family

ID=23567320

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95393A IL95393A0 (en) 1989-08-18 1990-08-16 Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing

Country Status (6)

Country Link
EP (1) EP0487648A4 (en)
JP (1) JPH05503071A (en)
AU (1) AU6425590A (en)
CA (1) CA2065044A1 (en)
IL (1) IL95393A0 (en)
WO (1) WO1991002538A1 (en)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW222591B (en) * 1991-08-30 1994-04-21 Procter & Gamble
IT1252061B (en) * 1991-11-22 1995-05-29 Gentili Ist Spa COMPOSITIONS FOR DERMATOLOGICAL AND COSMETIC USE
WO1993011735A1 (en) * 1991-12-18 1993-06-24 Advanced Oxygen Technologies, Inc. Treatment of fungal infections
DE4142319A1 (en) * 1991-12-20 1993-06-24 Henkel Kgaa wound antiseptic
US5645827A (en) * 1992-09-30 1997-07-08 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
US5358706A (en) * 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
FR2704394B1 (en) * 1993-04-27 1995-06-02 Boiron Absorbable nutritional supplement for the treatment of hair and nails.
FR2705564B1 (en) * 1993-05-25 1995-07-13 Oreal New process for permanent hair deformation and composition for its implementation containing in association an amino or amidothiol and at least one mineral bromide.
US6113893A (en) * 1993-07-28 2000-09-05 Pfizer Inc. Psoriasis treatment
AU693100B2 (en) * 1993-07-28 1998-06-25 Pfizer Inc. Psoriasis treatment
GB9515373D0 (en) * 1995-07-21 1995-09-20 Unilever Plc Hair styling method
FR2740341B1 (en) * 1995-10-26 1997-12-19 Oreal USE OF LANTHANIDE SALT, TIN, ZINC, MANGANESE, YTTRIUM, COBALT, BARIUM, STRONTIUM IN A SKIN COMPOSITION
FR2740340B1 (en) * 1995-10-30 1997-12-05 Oreal USE OF CARBOXYLIC ACIDS CARRYING A SULFURED FUNCTION TO PROMOTE SKIN DEQUAMATION OR STIMULATE EPIDERMAL RENEWAL
GB2320431B (en) * 1996-12-20 2000-08-30 Johnson & Johnson Medical Compositions for the treatment of chronic wounds
DE69808898T2 (en) 1997-03-03 2003-08-07 Quest International B.V., Naarden HAIR CARE PRODUCT CONTAINING A SULFUR-REDUCING ACTIVE SUBSTANCE AND A ZINC COMPOUND
WO1998038975A1 (en) * 1997-03-03 1998-09-11 Quest International B.V. Hair treatment compositions containing reducing sulphur species and zinc compound
GB9711447D0 (en) * 1997-04-09 1997-07-30 Reckitt & Colman France
IT1291622B1 (en) * 1997-04-18 1999-01-11 Marcello Izzo USE OF THIOGLYCOLIC ACID AS A DEPIGMENTING AGENT
AU742369B2 (en) * 1997-09-26 2002-01-03 Shiseido Company Ltd. Dermatologic preparation
JP4111546B2 (en) * 1997-12-15 2008-07-02 ウルトラデント プロダクツ インコーポレイテッド Polymerizable isolation barrier and method of forming and using such a barrier
DE19831043A1 (en) * 1998-07-13 2000-01-27 Deutsches Krebsforsch Inhibition of alopecia
US6497893B1 (en) * 1999-06-30 2002-12-24 Kimberly-Clark Worldwide, Inc. Silk protein treatment composition and treated substrate for transfer to skin
AU2319400A (en) * 1999-01-28 2000-08-18 Shiseido Company Ltd. Compositions for external use
AU5901600A (en) * 1999-06-30 2001-01-31 Kimberly-Clark Worldwide, Inc. Delivery of a skin health benefit agent to a treated substrate for transfer to skin
US6506394B1 (en) 1999-06-30 2003-01-14 Kimberly-Clark Worldwide, Inc. Delivery of a botanical extract to a treated substrate for transfer to skin
US6500443B1 (en) 1999-06-30 2002-12-31 Kimberly-Clark Worldwide, Inc. Delivery of a sacrificial substrate to inhibit protease permeation into skin
US6503524B1 (en) 2000-06-16 2003-01-07 Kimberly-Clark Worldwide, Inc. Delivery of a skin health benefit agent to a treated substrate for transfer to skin
WO2002049587A1 (en) * 2000-12-19 2002-06-27 Unilever Plc Hair treatment composition
WO2003064449A2 (en) 2002-01-28 2003-08-07 Keraplast Technologies, Ltd. Bioactive keratin peptides
US20030219465A1 (en) * 2002-05-23 2003-11-27 Suresh Kumar Gidwani Composition for delivery of dithranol
CN1678339A (en) * 2002-08-30 2005-10-05 汉高两合股份公司 Synergistic combination of silk proteins
AT502435B1 (en) * 2002-11-19 2008-01-15 Oekopharm Forschungs Und Entwi PHARMACEUTICAL COMPOSITION COMPRISING A HYDROGEN-TRANSFERRING COENZYME AND CHLOROPHYLL
WO2007001339A2 (en) 2004-08-17 2007-01-04 Wake Forest University Health Sciences Ambient stored blood plasma expanders
DE102004046063A1 (en) * 2004-09-22 2006-03-23 Henkel Kgaa Hair treatment agent, useful to decrease olfactory absorption in keratinic fibers, comprises apolar components and protein-complex trace elements of e.g. zinc, magnesium, potassium or ferrous
GB0511499D0 (en) * 2005-06-06 2005-07-13 Medpharm Ltd Topical ungual formulations
US8920827B2 (en) 2005-10-21 2014-12-30 Wake Forest University Health Sciences Keratin bioceramic compositions
EP1991253B1 (en) 2006-02-10 2013-07-31 Wake Forest University Health Sciences Nerve regeneration employing keratin biomaterials
JP2009527274A (en) 2006-02-17 2009-07-30 ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ Coatings and biomedical implants formed from keratin biomedical materials
US8273702B2 (en) 2006-02-17 2012-09-25 Wake Forest University Health Sciences Wound healing compositions containing keratin biomaterials
JP2008063334A (en) * 2006-08-10 2008-03-21 Lion Corp Composition for attaching water soluble active ingredient and method for attaching the water soluble active ingredient
US9068162B2 (en) 2007-08-17 2015-06-30 Wake Forest University Health Sciences Keratin biomaterials for cell culture and methods of use
GB2458531A (en) * 2008-03-26 2009-09-30 Boots Co Plc Strengthening hair care composition comprising mild reducing agent
JP2013521313A (en) 2010-03-05 2013-06-10 ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ Controlled delivery system
WO2011112575A1 (en) 2010-03-08 2011-09-15 Wake Forest University Health Sciences Keratin biomaterials for treatment of ischemia
WO2012068376A2 (en) 2010-11-17 2012-05-24 Wake Forest University Health Sciences Keratin compositions for treatment of bone deficiency or injury
ES2617492T3 (en) * 2012-12-19 2017-06-19 Colgate-Palmolive Company Antiperspirant products with protein and antiperspirant salts
CA2969239C (en) * 2014-12-12 2022-04-26 Robert Valentine Kasowski Method for preparing sodium free ethyleneamine polyphosphate (eappa) for flame retardant uses
KR102426006B1 (en) * 2016-04-13 2022-07-29 노반, 인크. Compositions, systems, kits, and methods for treating infections
EP3544573A1 (en) * 2016-11-25 2019-10-02 Urgo Recherche Innovation et Développement Film-forming composition
CN113134028B (en) * 2021-04-28 2022-04-12 维尼健康(深圳)股份有限公司 Wound disinfectant and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3842848A (en) * 1971-05-27 1974-10-22 Wilson Sinclair Co Keratin polypeptide hydrolyzates as hair treating agents
US4438102A (en) * 1982-08-10 1984-03-20 Ciro's Touch, Ltd. Method of promoting tissue growth
GB2160419B (en) * 1984-06-08 1990-02-14 Crestol Ltd Treatment of hair, skin and nails
CA1278750C (en) * 1985-07-23 1991-01-08 Nobuo Kobayashi Aqueous deodorants and deodorizing methods
CA1324764C (en) * 1988-07-13 1993-11-30 Aikoh Co., Ltd. Reaction typed deodorant composition having a corrosion-inhibiting activity
ATE118350T1 (en) * 1988-07-22 1995-03-15 Morris John Co Inc COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES AND ACTIVATE WOUND HEALING.

Also Published As

Publication number Publication date
JPH05503071A (en) 1993-05-27
EP0487648A1 (en) 1992-06-03
CA2065044A1 (en) 1991-02-19
WO1991002538A1 (en) 1991-03-07
EP0487648A4 (en) 1993-03-31
AU6425590A (en) 1991-04-03

Similar Documents

Publication Publication Date Title
IL95393A0 (en) Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing
GB2188060B (en) Aqueous delayed-foaming cosmetic composition for hair and skin treatment
NZ233410A (en) Cosmetic hair treatment composition
BR9103504A (en) COMPOSITION FOR THE TREATMENT OF HAIR, FIBER OR SKIN, HAVING IMPROVED STABILITY AT HIGH TEMPERATURES
HU910312D0 (en) Preparation for treating human nails
EP0330496A3 (en) Skin treatment composition
ZW5990A1 (en) Hair treatment composition
EP0588477A3 (en) Medicinal composition comprising tcf-ii
EP0403530A4 (en) Storage-stable compositions and methods for treating keratinous tissue
GB9405021D0 (en) Skin treatment composition
GB8804531D0 (en) Skin treatment formulations
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
AU2143892A (en) Use of formoterol for treatment of tissue injury
GB9405046D0 (en) Skin treatment composition
AU5448490A (en) Compositions and processes for improving the cosmetic appearance, growths or healing characteristics of tissue
IL91582A0 (en) Compositions for treating acne,for disinfecting the skin and the hair and for treating the hair
HU9700079D0 (en) Topical compositions for the treatment of skin disease
ZA979135B (en) New cosmetic, dermopharmaceutical or veterinary compositions for the antiseptic treatment of human or animal skin.
HU911720D0 (en) Medicative cream for treating acut and chronical pain, for improving the working of organs
GB8903519D0 (en) Skin treatment composition
HU903254D0 (en) Medicative cosmetic substance for skin care and cleaning, preferably for preventing or treating acne vulgaris
AU1104888A (en) Cosmetic agent and composition for skin treatment
ZA906258B (en) Hair treatment composition
IL89438A0 (en) Storage stable compositions and methods for treating keratinous tissue
GB8819737D0 (en) Skin treatment composition